WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced its third quarter 2025 financial results and business highlights.
Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
Seeking Alpha / 2 hours ago 1 Views
Comments